Report Detail

Pharma & Healthcare Global Tyrosine Kinase Inhibitors Market Professional Survey Report 2019

  • RnM3813158
  • |
  • 14 October, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.
The global tyrosine kinase inhibitors market is expanding owing to high prevalence and increase in incidence of cancer across the globe.

The global Tyrosine Kinase Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Kinase Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Kinase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Tyrosine Kinase Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca
Pfizer
Novartis
Bristol-Myers Squibb
Bayer
Boehringer Ingelheim International
F. Hoffmann-La Roche
Johnson & Johnson
Eisai

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BCR-ABL Tyrosine Kinase Inhibitor
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors

Segment by Application
Chronic Myeloid Leukemia (CML)
Lung Cancer
Breast Cancer
Renal Cell Cancer
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Tyrosine Kinase Inhibitors

      • 1.1 Definition of Tyrosine Kinase Inhibitors
      • 1.2 Tyrosine Kinase Inhibitors Segment by Type
        • 1.2.1 Global Tyrosine Kinase Inhibitors Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 BCR-ABL Tyrosine Kinase Inhibitor
        • 1.2.3 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
        • 1.2.4 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
      • 1.3 Tyrosine Kinase Inhibitors Segment by Applications
        • 1.3.1 Global Tyrosine Kinase Inhibitors Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Chronic Myeloid Leukemia (CML)
        • 1.3.3 Lung Cancer
        • 1.3.4 Breast Cancer
        • 1.3.5 Renal Cell Cancer
        • 1.3.6 Others
      • 1.4 Global Tyrosine Kinase Inhibitors Overall Market
        • 1.4.1 Global Tyrosine Kinase Inhibitors Revenue (2014-2025)
        • 1.4.2 Global Tyrosine Kinase Inhibitors Production (2014-2025)
        • 1.4.3 North America Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
        • 1.4.4 Europe Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
        • 1.4.5 China Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
        • 1.4.6 Japan Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
        • 1.4.8 India Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Tyrosine Kinase Inhibitors
      • 2.3 Manufacturing Process Analysis of Tyrosine Kinase Inhibitors
      • 2.4 Industry Chain Structure of Tyrosine Kinase Inhibitors

      3 Development and Manufacturing Plants Analysis of Tyrosine Kinase Inhibitors

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Tyrosine Kinase Inhibitors Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Tyrosine Kinase Inhibitors
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Tyrosine Kinase Inhibitors Production and Capacity Analysis
      • 4.2 Tyrosine Kinase Inhibitors Revenue Analysis
      • 4.3 Tyrosine Kinase Inhibitors Price Analysis
      • 4.4 Market Concentration Degree

      5 Tyrosine Kinase Inhibitors Regional Market Analysis

      • 5.1 Tyrosine Kinase Inhibitors Production by Regions
        • 5.1.1 Global Tyrosine Kinase Inhibitors Production by Regions
        • 5.1.2 Global Tyrosine Kinase Inhibitors Revenue by Regions
      • 5.2 Tyrosine Kinase Inhibitors Consumption by Regions
      • 5.3 North America Tyrosine Kinase Inhibitors Market Analysis
        • 5.3.1 North America Tyrosine Kinase Inhibitors Production
        • 5.3.2 North America Tyrosine Kinase Inhibitors Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Tyrosine Kinase Inhibitors Import and Export
      • 5.4 Europe Tyrosine Kinase Inhibitors Market Analysis
        • 5.4.1 Europe Tyrosine Kinase Inhibitors Production
        • 5.4.2 Europe Tyrosine Kinase Inhibitors Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Tyrosine Kinase Inhibitors Import and Export
      • 5.5 China Tyrosine Kinase Inhibitors Market Analysis
        • 5.5.1 China Tyrosine Kinase Inhibitors Production
        • 5.5.2 China Tyrosine Kinase Inhibitors Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Tyrosine Kinase Inhibitors Import and Export
      • 5.6 Japan Tyrosine Kinase Inhibitors Market Analysis
        • 5.6.1 Japan Tyrosine Kinase Inhibitors Production
        • 5.6.2 Japan Tyrosine Kinase Inhibitors Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Tyrosine Kinase Inhibitors Import and Export
      • 5.7 Southeast Asia Tyrosine Kinase Inhibitors Market Analysis
        • 5.7.1 Southeast Asia Tyrosine Kinase Inhibitors Production
        • 5.7.2 Southeast Asia Tyrosine Kinase Inhibitors Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Tyrosine Kinase Inhibitors Import and Export
      • 5.8 India Tyrosine Kinase Inhibitors Market Analysis
        • 5.8.1 India Tyrosine Kinase Inhibitors Production
        • 5.8.2 India Tyrosine Kinase Inhibitors Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Tyrosine Kinase Inhibitors Import and Export

      6 Tyrosine Kinase Inhibitors Segment Market Analysis (by Type)

      • 6.1 Global Tyrosine Kinase Inhibitors Production by Type
      • 6.2 Global Tyrosine Kinase Inhibitors Revenue by Type
      • 6.3 Tyrosine Kinase Inhibitors Price by Type

      7 Tyrosine Kinase Inhibitors Segment Market Analysis (by Application)

      • 7.1 Global Tyrosine Kinase Inhibitors Consumption by Application
      • 7.2 Global Tyrosine Kinase Inhibitors Consumption Market Share by Application (2014-2019)

      8 Tyrosine Kinase Inhibitors Major Manufacturers Analysis

      • 8.1 AstraZeneca
        • 8.1.1 AstraZeneca Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.1.2 AstraZeneca Product Introduction, Application and Specification
        • 8.1.3 AstraZeneca Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Pfizer
        • 8.2.1 Pfizer Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.2.2 Pfizer Product Introduction, Application and Specification
        • 8.2.3 Pfizer Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis
        • 8.3.1 Novartis Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.3.2 Novartis Product Introduction, Application and Specification
        • 8.3.3 Novartis Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Bristol-Myers Squibb
        • 8.4.1 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.4.3 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bayer
        • 8.5.1 Bayer Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.5.2 Bayer Product Introduction, Application and Specification
        • 8.5.3 Bayer Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Boehringer Ingelheim International
        • 8.6.1 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.6.2 Boehringer Ingelheim International Product Introduction, Application and Specification
        • 8.6.3 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 F. Hoffmann-La Roche
        • 8.7.1 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.7.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
        • 8.7.3 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Johnson & Johnson
        • 8.8.1 Johnson & Johnson Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.8.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.8.3 Johnson & Johnson Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Eisai
        • 8.9.1 Eisai Tyrosine Kinase Inhibitors Production Sites and Area Served
        • 8.9.2 Eisai Product Introduction, Application and Specification
        • 8.9.3 Eisai Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Tyrosine Kinase Inhibitors Market

      • 9.1 Global Tyrosine Kinase Inhibitors Market Trend Analysis
        • 9.1.1 Global Tyrosine Kinase Inhibitors Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Tyrosine Kinase Inhibitors Regional Market Trend
        • 9.2.1 North America Tyrosine Kinase Inhibitors Forecast 2019-2025
        • 9.2.2 Europe Tyrosine Kinase Inhibitors Forecast 2019-2025
        • 9.2.3 China Tyrosine Kinase Inhibitors Forecast 2019-2025
        • 9.2.4 Japan Tyrosine Kinase Inhibitors Forecast 2019-2025
        • 9.2.5 Southeast Asia Tyrosine Kinase Inhibitors Forecast 2019-2025
        • 9.2.6 India Tyrosine Kinase Inhibitors Forecast 2019-2025
      • 9.3 Tyrosine Kinase Inhibitors Market Trend (Product Type)
      • 9.4 Tyrosine Kinase Inhibitors Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Tyrosine Kinase Inhibitors Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Tyrosine Kinase Inhibitors. Industry analysis & Market Report on Tyrosine Kinase Inhibitors is a syndicated market report, published as Global Tyrosine Kinase Inhibitors Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Tyrosine Kinase Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,667.00
        4,000.50
        5,334.00
        3,185.00
        4,777.50
        6,370.00
        517,790.00
        776,685.00
        1,035,580.00
        294,105.00
        441,157.50
        588,210.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report